Trial intelligence / Profile preview

DCA with Cisplatin and Radiation in Head and Neck Cancer

NCT01386632Phase 2Completed

Sponsor
Sanford Health
Start
May 2011
Primary completion
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dichloroacetate in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Sanford Health. Started May 2011; status: completed.

02

Drugs

dichloroacetate
03

Conditions

squamous cell carcinoma of the head and neck (HNSCC)

Beyond the preview

Go deeper on NCT01386632.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01386632.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call